Additionally, LPS upregulates programmed cell death ligand 1 (PD-L1) through the TLR4/MyD88/AKT/NF-κB signaling pathway and induces the depletion and apoptosis of tumor-infiltrating lymphocytes (TILs), thereby promoting cancer immune evasion (79). This evidence concerns the gene NFKB1 and cancer.